TrialRespiratory research2017

24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD.

Colin Reisner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.